The diabetes market has undergone a transformation in the past five years as continuous glucose monitoring (CGM) continues to change lives.
According to Close Concerns, a diabetes industry organization, the global diabetes market was $19.9 billion in Q2 2023 and the global CGM market was $2.4 billion in Q2 2023.
A leading medical device and digital health platform company in the U.S. wants to move closer to becoming a leader in the diabetes market and is aligning closer to service this specific market.
Diabetes specialist Glucotrack (NASDAQ:GCTK) recently announced a change in its business strategy, with a transition from non-invasive point-in-time glucose monitoring to continuous glucose monitoring.
During this past half decade, the team has seen declining interest and shrinking revenues for blood glucose point-in-time monitoring, which has been a catalyst for this pivot in business.
“We believe that the…
